ASN thanks the approximately 12,000 participants of Kidney Week 2025 from across the globe for another successful meeting.
November 4, 2025
Onsite Registration Opens in Houston
November 5, 2025
Early Programs in Houston
November 6-9, 2025
Annual Meeting
View All#KidneyWk on X 12 hours ago
RT @Eledon_Pharma: Check out this podcast from @ASNKidney highlighting the results of our Phase 2 BESTOW trial presented at #KidneyWk and t…
View Post
#KidneyWk on X 12 hours ago
Check out this podcast from @ASNKidney highlighting the results of our Phase 2 BESTOW trial presented at #KidneyWk and the potential of tegoprubart...
View Post
#KidneyWk on X 13 hours ago
👀 WATCH NOW: Joel Topf @kidney_boy caught up with @AgarwalRajivMD at #KidneyWk in Houston, where the latter presented CONFIDENCE findings on imple...
View Post
#KidneyWk on X 15 hours ago
RT @Neph_Times: Another #KidneyWk, another showcase for #IgAN therapies. Joel Topf @kidney_boy spoke with Jonathan Barratt about his trials…
View Post
#KidneyWk on X 15 hours ago
RT @Neph_Times: Our #KidneyWk coverage continues to roll out. Next up is our interview with Vlado Perkovic on the possibility of curing #ki…
View Post
#KidneyWk on X 1 day ago
RT @JasmineNephro: 🧬🧬Some monogenic kidney disease with specific therapies 👍 🧬👇#KidneyWk ✅Fabry-Enzyme replacement ✅ATTR amyloid-Patisi…
View Post
#KidneyWk on X 1 day ago
Another #KidneyWk, another showcase for #IgAN therapies. Joel Topf @kidney_boy spoke with Jonathan Barratt about his trials of mezagitamab and atac...
View Post
#KidneyWk on X 1 day ago
RT @Eledon_Pharma: New data from our Phase 2 BESTOW trial presented at #KidneyWk 2025 reinforce the potential of tegoprubart, our investiga…
View Post
#KidneyWk on X 1 day ago
New data from our Phase 2 BESTOW trial presented at #KidneyWk 2025 reinforce the potential of tegoprubart, our investigational therapy being evalua...
View Post
#KidneyWk on X 1 day ago
Upcoming CSN webinar Next Monday, David Cherney from Toronto will present on CKM updates from #KidneyWk https://t.co/m79VBgiaS2 https://t.co/E5...
View Post